Mark Ellis - Concepedia

Author

Mark Ellis

Burroughs Wellcome Fund ORCID

Also Known As

Ellis, Mark, M N Ellis, M. N. Ellis, M. Nixon Ellis, M.N. ELLIS, M.N. Ellis, M.Nixon Ellis, Mark Ellis

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Burroughs Wellcome Fund Research Triangle Park Foundation UCB Pharma (United Kingdom)

About

Mark Ellis is an author at Burroughs Wellcome Fund specializing in medicine, immunology, and virology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	23	1.1K
2	Health Sciences	2	2	112
3	Allergy	1	1	30
4	Cell Biology	1	1	21
5	Hepatology	1	1	39

Mark Ellis

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents C. McLaren, Mark Ellis, G.A. Hunter Antiviral Research Colorimetric AssayDiagnostic VirologyAntiviral AgentsViral DiagnosticsBioanalysis	1983	149
In vitro and in vivo characterization of herpes simplex virus clinical isolates recovered from patients infected with human immunodeficiency virus Edgar L. Hill, G.A. Hunter, Mark Ellis Antimicrobial Agents and Chemotherapy ImmunologyViral PathogenesisPathologyClinical IsolatesHuman Immunodeficiency Virus	1991	131
Acyclovir-Resistant Herpes Simplex Virus Causing Pneumonia after Marrow Transplantation Per Ljungman, Mark Ellis, Robert C. Hackman, The Journal of Infectious Diseases Diagnostic VirologyMarrow Transplant PatientsTransplantationMarrow TransplantationViral Persistence	1990	109
Sensitivity monitoring of clinical isolates of herpes simplex virus to acyclovir Peter Collins, Mark Ellis Journal of Medical Virology Viral DiagnosticsImmunologyPathologyAntiviral DrugClinical Isolates	1993	85
Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity Mark Ellis, Paul M. Keller, James A. Fyfe, Antimicrobial Agents and Chemotherapy Clinical IsolateDiagnostic VirologyDrug SusceptibilityAltered Substrate SpecificityMolecular Virology	1987	82
Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolates J L Martin, Mark Ellis, Paul M. Keller, Antimicrobial Agents and Chemotherapy Diagnostic VirologyMolecular VirologyViral PersistenceViral DiagnosticsPlaque Autoradiography	1985	67
An affinity-enhanced, broadly neutralizing heavy chain–only antibody protects against SARS-CoV-2 infection in animal models Bert Schepens, Loes van Schie, Wim Nerinckx, Science Translational Medicine	2021	66
Nucleotide sequence changes in thymidine kinase gene of herpes simplex virus type 2 clones from an isolate of a patient treated with acyclovir Saul Kit, Mary N. Sheppard, Hiroshi Ichimura, Antimicrobial Agents and Chemotherapy Tk GeneMolecular VirologyMedicinePathogenesisImmunology	1987	62
Disseminated cryptococcal infection in a patient with hypogammaglobulinemia and normal T cell functions Sudhir Gupta, Mark Ellis, Thomas C. Cesario, The American Journal of Medicine Primary ImmunodeficiencyImmunodeficienciesPathogenesisImmunologyCryptococcal Infection	1987	52
A Mixture of Functionally Oligoclonal Humanized Monoclonal Antibodies That Neutralize Clostridium difficile TcdA and TcdB with High Levels of<i>In Vitro</i>Potency Shows<i>In Vivo</i>Protection in a Hamster Infection Model Nicola L. Davies, Joanne Compson, Brendon MacKenzie, Clinical and Vaccine Immunology Microbial PathogensImmunologyImmunodominanceImmune SystemImmunotherapy	2013	51

Page 1